Burosumab - CAS 1610833-03-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
COA:
Inquire
Targets:
Others
Description:
Burosumab is a human monoclonal antibody targeting the phosphaturic hormone fibroblast growth factor 23 (FGF23). Burosumab is currently in a phase III clinical trial for the treatment of patients with X-linked hypophosphatemia.
Brife Description:
human monoclonal antibody
Synonyms:
KRN-23; KRN 23; KRN23
MSDS:
Inquire
Application:
the potential treatment of X-linked hypophosphatemia
Current Developer:
Ultragenyx Pharmaceutical; Kyowa Hakko Kirin
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 518-69-4 Corydaline

Corydaline
(CAS: 518-69-4)

Corydaline, extracted from Corydalis ambigua, is one of the major active constituents in a new prokinetic botanical agent exhibiting the antiacetylcholinesteras...

CAS 37519-14-5 3-Hydroxyacetaminophen

3-Hydroxyacetaminophen
(CAS: 37519-14-5)

A metabolite of acetaminophen, which is is a pain reliever and a fever reducer.

CAS 25487-28-9 Talsupram hydrochloride

Talsupram hydrochloride
(CAS: 25487-28-9)

Talsupram hydrochloride is a selective noradrenalin reuptake (SLC6A2) inhibitor, displaying high affinity for the human noradrenalin transporter (NET) against S...

PKR-IN-2
(CAS: 1628428-01-2)

PKR-IN-2 is a pyruvate kinase (PKR) activator. IC50: PKR (R510Q) <100 nM

CAS 67-48-1 Choline Chloride

Choline Chloride
(CAS: 67-48-1)

Choline chloride is a quaternary ammonium salt used as an additive for animal feed, especially for chickens where it accelerates growth.

CAS 478-01-3 Nobiletin

Nobiletin
(CAS: 478-01-3)

Nobiletin, a citrus flavonoid isolated from citrus peels like in tangerine, which has anti-inflammatory and anti-tumor activities.

LY 140091
(CAS: 74814-56-5)

LY 140091 is a bio-active chemical, but no detailed information has been published yet.

BI-44847
(CAS: 421592-30-5)

BI-44847 is a synthetic bio-active chemical had been in phase II clinical trials for the treatment of type 2 diabetes.

Quick Inquiry

Verification code

Featured Items